Overview

The UTHealth Ketamine Project

Status:
Terminated
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the effectiveness of serial infusions of intravenous (IV) ketamine in adults with treatment resistant depression (TRD).
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Ketamine